Sex, Drugs, and Commercial Speech: The Contested Discourse of Truvada.Published in:Columbia Journal of Law & Social Problems, 2017, v. 50, n. 3, p. 1By:LAWLESS, JOSEPH F.Publication type:Article
IN DEFENSE OF THE FDA'S PROHIBITION AGAINST OFF-LABEL PHARMACEUTICAL MARKETING: THE FIRST AMENDMENT DOES NOT STAND IN THE WAY.Published in:Michigan State Law Review, 2016, v. 2016, n. 5, p. 1409By:Vigil, Hilary LandgrafPublication type:Article
United States District Court for the Southern District of New York Grants Preliminary Injunction Against FDA for Regulations of Off-Label Promotion - Amarin Pharma, Inc. v. U.S. Food & Drug Admin.Published in:American Journal of Law & Medicine, 2015, v. 41, n. 4, p. 688, doi. 10.1177/0098858815622194By:Osterman, LewisPublication type:Article